T-Cell Therapy Development Studies Rely on HemaCare Leukopaks to Facilitate Donor Sourcing
T-Cell Therapy Development Studies Rely on HemaCare Leukopaks to Facilitate Donor Sourcing
2 PagesCustomer Case Study | European-Based Cell Therapy Institute | Leukopak T-Cell Therapy Development Studies Rely on HemaCare Leukopaks to Facilitate Donor Sourcing Introduction The development of cell and gene based therapies in the United Kingdom is currently getting a well-deserved boost. The U.K. government has invested heavily in the sector, to the extent of funding an impressive new research facility for a non-profit cell therapy organization, which hosts clients from both the U.K. and other European nations who are developing novel cell and gene based therapies. Clients are provided with the infrastructure to enable promising new therapies to be translated more smoothly and rapidly into commercially viable treatments. Because the European based cell therapy company sponso
